Completed PHASE4 INTERVENTIONAL NCT00477789
Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients
Sponsor: Universita di Verona
Conditions
Chronic Heart Failure
Interventions
allopurinol
Updated 5 times since 2017 Last updated: May 23, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Chronic Heart Failure and is currently completed. Universita di Verona leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Universita di Verona
Data source: Universita di Verona
For direct contact, visit the study record on ClinicalTrials.gov .